Clinical Immunoassay for Human Hepcidin Predicts Iron Deficiency in First-Time Blood Donors. (24th April 2020)

• Record Type: Journal Article
• Authors: Gutschow, Patrick; Han, Huiling; Olbina, Gordana; Westerman, Keith; Nemeth, Elizabeta; Ganz, Tomas; Copeland, Karen; Westerman, Mark; Ostland, Vaughn
• Is Part Of: Journal of applied laboratory medicine. Volume 5:Number 5(2020)
• Page Start: 943
• Page End: 953
• Publication Date: 2020-04-24
• Subjects: Hepcidin -- ELISA -- Iron Deficiency -- Anemia; Clinical chemistry -- Periodicals; Diagnosis, Laboratory -- Periodicals; 616.0756
• DOI: 10.1093/jalm/jfaa038
• Languages: English
• ISSNs: 2576-9456

Abstract

Abstract: Background: Serum markers currently used as indicators of iron status have clinical limitations. Hepcidin, a key regulator of iron homeostasis, is reduced in iron deficiency (ID) and increased in iron overload. We describe the first CLIA-validated immunoassay with excellent accuracy and precision to quantify human serum hepcidin. Its diagnostic utility for detecting ID in first-time blood donors was demonstrated. Methods: A monoclonal competitive ELISA (C-ELISA) was developed for the quantitation of human hepcidin and validated according to CLIA guidelines. Sera from nonanemic first-time blood donors (n = 292) were analyzed for hepcidin, ferritin, transferrin, and serum iron. Logistic regression served to determine the utility of hepcidin as a predictor of ID. Results: The C-ELISA was specific for human hepcidin and had a low limit of quantitation (4.0 ng/mL). The hepcidin concentration measured with the monoclonal C-ELISA was strongly correlated with a previously established, extensively tested polyclonal C-ELISA ( Blood 2008;112:4292–7) ( r = 0.95, P < 0.001). The area under the receiver operating characteristic curve for hepcidin as a predictor of ID, defined by 3 ferritin concentration thresholds, was >0.9. For predicting ID defined by ferritin <15 ng/mL, hepcidin <10 ng/mL yielded sensitivity of 93.1% and specificity of 85.5%, whereas the same hepcidin cutoff for ferritin <30 ng/mL yielded sensitivity of 67.6% and specificity of 91.7%. Conclusion: The clinical measurement of serum hepcidin concentrations was shown to be a potentially useful tool for diagnosing ID.